O'Callaghan E - Search Results

1

Compliance therapy: a randomised controlled trial in schizophrenia.

O'Donnell C, Donohoe G, Sharkey L, Owens N, Migone M, Harries R, Kinsella A, Larkin C, O'Callaghan E. O'Donnell C, et al. BMJ. 2003 Oct 11;327(7419):834. doi: 10.1136/bmj.327.7419.834. BMJ. 2003. PMID: 14551096 Free PMC article. Clinical Trial.

2

Evidence that health attributions and symptom severity predict insight in schizophrenia.

Donohoe G, Donnell CO, Owens N, O'Callaghan E. Donohoe G, et al. J Nerv Ment Dis. 2004 Sep;192(9):635-7. doi: 10.1097/01.nmd.0000138318.05729.db. J Nerv Ment Dis. 2004. PMID: 15348981

3

Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E. Donohoe G, et al. Eur Psychiatry. 2001 Aug;16(5):293-8. doi: 10.1016/s0924-9338(01)00581-8. Eur Psychiatry. 2001. PMID: 11514132

4

Effect of social class at birth on risk and presentation of schizophrenia: case-control study.

Mulvany F, O'Callaghan E, Takei N, Byrne M, Fearon P, Larkin C. Mulvany F, et al. BMJ. 2001 Dec 15;323(7326):1398-401. doi: 10.1136/bmj.323.7326.1398. BMJ. 2001. PMID: 11744563 Free PMC article.

5

Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness.

Whitty P, Clarke M, McTigue O, Browne S, Gervin M, Kamali M, Lane A, Kinsella A, Waddington J, Larkin C, O'Callaghan E. Whitty P, et al. Schizophr Res. 2006 Sep;86(1-3):110-7. doi: 10.1016/j.schres.2006.04.012. Epub 2006 Jun 9. Schizophr Res. 2006. PMID: 16765029

6

Nonadherence to medication four years after a first episode of psychosis and associated risk factors.

Hill M, Crumlish N, Whitty P, Clarke M, Browne S, Kamali M, Kinsella A, Waddington JL, Larkin C, O'Callaghan E. Hill M, et al. Psychiatr Serv. 2010 Feb;61(2):189-92. doi: 10.1176/ps.2010.61.2.189. Psychiatr Serv. 2010. PMID: 20123826

7

A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness.

Madigan K, Brennan D, Lawlor E, Turner N, Kinsella A, O'Connor JJ, Russell V, Waddington JL, O'Callaghan E. Madigan K, et al. Schizophr Res. 2013 Jan;143(1):138-42. doi: 10.1016/j.schres.2012.10.018. Epub 2012 Nov 24. Schizophr Res. 2013. PMID: 23187069 Clinical Trial.

8

Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia.

O'Callaghan E, Larkin C, Kinsella A, Waddington JL. O'Callaghan E, et al. Br J Psychiatry. 1990 Oct;157:578-84. doi: 10.1192/bjp.157.4.578. Br J Psychiatry. 1990. PMID: 1983389

9

Familial, obstetric, and other clinical correlates of minor physical anomalies in schizophrenia.

O'Callaghan E, Larkin C, Kinsella A, Waddington JL. O'Callaghan E, et al. Am J Psychiatry. 1991 Apr;148(4):479-83. doi: 10.1176/ajp.148.4.479. Am J Psychiatry. 1991. PMID: 2006694

10

Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?

Waddington JL, O'Callaghan E, Larkin C, Kinsella A. Waddington JL, et al. Brain Cogn. 1993 Sep;23(1):56-70. doi: 10.1006/brcg.1993.1044. Brain Cogn. 1993. PMID: 8105822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters